; (B) conditions that facilitate indoor residential mold growth; or (C) indicia of conditions that are likely to facilitate indoor residential mold growth. (3) Toxigenic mold The term toxigenic mold means any indoor mold growth that may be capable of producing a toxin or toxic compound, including mycotoxins and mVOCs, that can cause pulmonary, respiratory, neurological, gastrointestinal, or dermatological illnesses, or other major adverse health impacts, as jointly determined by the Director of the National Institutes of Health, the Secretary of Housing and Urban Development, the Administrator of the Environmental Protection Agency, and the Director of the Centers for Disease Control and Prevention. 3. Interagency research on health impacts of indoor residential mold (a) Research (1) In general As soon as practicable after the date of enactment of this Act, the Director of the National Institute of Environmental Health Sciences at the National Institutes of Health, in conjunction with the Secretary of Housing and Urban Development, the Director of the Centers for Disease Control and Prevention, the Administrator of the Environmental Protection Agency, the Secretary of Energy, the Secretary of Health and Human Services, the President of the National Academy of Sciences, and the Chair of the board of directors of the National Institute of Building Sciences shall jointly conduct a comprehensive study of the health effects of indoor residential mold growth, using the most up-to-date scientific peer-reviewed medical literature. (2) Contents The study conducted under paragraph (1) shall ascertain, among other things— (A) detailed information about harmful or toxigenic mold, as well as any toxin or toxic compound such mold can produce; (B) the most accurate research-based methods of detecting harmful or toxigenic mold; (C) potential dangers of prolonged or chronic exposure to indoor residential mold growth